Physician profile
Vladimir I Vekstein
NPI 1467560300
$1,672.62
in general payments reported to CMS, 2019-2025
21 companies · $189 in 2025
The $189 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $289 · 2020: $233 · 2021: $126 · 2022: $277 · 2023: $391 · 2024: $169 · 2025: $189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $748.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $748.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $469.56 | 2020-2025 | Vigilant X4 Crt-D, Sq-Rx Pulse Generator, Watchman Flx |
| Amgen INC. | $164.37 | 2019-2023 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $151.82 | 2019-2025 | Eliquis, Camzyos |
| Novo Nordisk INC | $121.98 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Alexion Pharmaceuticals, INC. | $106.46 | 2022 | |
| Novartis Pharmaceuticals Corporation | $105.53 | 2021-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $100.02 | 2019-2025 | Lifevest |
| Abiomed | $72.04 | 2019 | |
| Abbott Laboratories | $65.77 | 2021-2023 | Diamondback Coronary |
| Teleflex LLC | $49.21 | 2019-2020 | |
| Shockwave Medical, INC | $45.01 | 2021-2025 | |
| Medtronic, INC. | $43.88 | 2023 | Onyx Frontier |
| Pfizer INC. | $36.89 | 2019-2023 | |
| Ekos Corporation | $23.99 | 2019 | |
| Biosense Webster, INC. | $23.75 | 2025 | Nuvision Ice Catheter, Carto 3 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $18.81 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $16.67 | 2019 | |
| Portola Pharmaceuticals, LLC | $15.99 | 2019 | |
| Cardiovascular Systems INC. | $14.77 | 2019-2020 | |
| Terumo Medical Corporation | $13.20 | 2020 | |
| Sanofi-Aventis U.S. LLC | $12.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vladimir Vekstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.